Cresco Labs establishes up to $100M at-the-market equity program
Source: SeekingAlpha
2026-01-30 06:41:27 ET
More on Cresco Labs
- Cresco Labs Benefits From Cannabis Rescheduling
- Cresco Labs Inc. (CRLBF) Q3 2025 Earnings Call Transcript
- Cresco Labs Inc. 2025 Q3 - Results - Earnings Call Presentation
- Trump reportedly seeks finalization of marijuana rescheduling by January-end
- GOP Rep. Lawler calls marijuana 'gateway drug' in opposing Trump rescheduling plan
Read the full article on Seeking Alpha
For further details see:
Cresco Labs establishes up to $100M at-the-market equity program
Cresco Labs Inc. (Sub Voting)
NASDAQ: CRLBF
CRLBF Trading
1.9% G/L:
$0.954 Last:
100,923 Volume:
$0.9102 Open:
CRLBF Latest News
March 05, 2026 06:30:00 am
Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement
CRLBF Stock Data
$374,894,090
350,757,188
7.22%
23
N/A
Pharmaceuticals
Healthcare
US
Chicago
